Early signs of supply tightening are beginning to emerge across global medicine supply chains, despite no significant increase in official shortage notifications. In practice, disruption appears first in supplier behaviour, lead times, and freight complexity—well before it is reflected in formal data.

After successfully gaining TGA GMP site approval for manufacturing site we are able to offer "Site Transfer" to the approved site. This site is approved for Tablet and Capsule manufacturing, packing and release. The site also has EU GMP and will provide Pro Pharm opportunities to explore projects using this site. Pro PG is the Australian Sponsor of this site and we look forward to filing and registering finished products with the TGA. Please contact us to discuss any Site T

Pro PG has our own team of Regulatory experts able to review dossiers, arrange TGA site inspections and also manage all Marketing Authorisation (MA) filing for Australia with the TGA. We also work with our European partner on BE studies and are able to arrange these.